Propanc Biopharma (PPCB) Convertible Debt (2014 - 2025)
Propanc Biopharma (PPCB) posted Convertible Debt of $65,280 for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 56.3% from $149,400 a year earlier and down 50.2% from the prior quarter.
Powered by 
Analysis
Propanc Biopharma (PPCB) Convertible Debt (2014 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Propanc Biopharma's Convertible Debt came in at $291,650, up 163.9% from FY2024.
- Annual Convertible Debt shows a five-year compound annual growth rate of 18.2% (FY2020 to FY2025).
- In prior fiscal years, Propanc Biopharma's Convertible Debt was $110,500 in FY2024 (+46.7%), $75,300 in FY2023 (-4.7%), $79,000 in FY2022 (-1.3%) and $80,000 in FY2021 (-36.8%).
- The fiscal Q2 2026 figure stands as the lowest quarterly Convertible Debt since fiscal Q2 2021.
- On a year-over-year basis, Convertible Debt increased in six of the last eight quarters, with growth averaging 37.9%.
- The strongest year-over-year quarter for Convertible Debt in the past five years was fiscal Q2 2022, with growth of 841.2%; the weakest was fiscal Q2 2026, with a decline of 56.3%.
- According to Business Quant data, Convertible Debt for the three prior fiscal quarters was $131,000 (Q1 2026), $291,650 (Q4 2025) and $211,650 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Propanc Biopharma | 595,565.74 | 595,565.74 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 65,280.00 |
| Sep 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 291,650.00 |
| Mar 31, 2025 | 211,650.00 |
| Dec 31, 2024 | 149,400.00 |
| Sep 30, 2024 | 145,700.00 |
| Jun 30, 2024 | 110,500.00 |
| Mar 31, 2024 | 122,500.00 |
| Dec 31, 2023 | 138,500.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 75,300.00 |
| Mar 31, 2023 | 121,500.00 |
| Dec 31, 2022 | 164,500.00 |
| Sep 30, 2022 | 164,500.00 |
| Jun 30, 2022 | 79,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 80,000.00 |
| Jun 30, 2021 | 80,000.00 |
| Mar 31, 2021 | 80,000.00 |
API Access
Propanc Biopharma Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();